pubmed-article:16783809 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C2265759 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1705241 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1516691 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
pubmed-article:16783809 | lifeskim:mentions | umls-concept:C1705242 | lld:lifeskim |
pubmed-article:16783809 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16783809 | pubmed:dateCreated | 2006-6-22 | lld:pubmed |
pubmed-article:16783809 | pubmed:abstractText | Pattern analysis has identified two types of response patterns to antidepressants: "true drug" response (TDR) and "placebo pattern" response (PPR). This study examines the relationship between cognitive factors and TDR and PPR to fluoxetine. | lld:pubmed |
pubmed-article:16783809 | pubmed:language | eng | lld:pubmed |
pubmed-article:16783809 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16783809 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16783809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16783809 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16783809 | pubmed:month | Jun | lld:pubmed |
pubmed-article:16783809 | pubmed:issn | 0885-6222 | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:PapakostasGeo... | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:FavaMaurizioM | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:MischoulonDav... | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:SonawallaSham... | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:FarabaughAmy... | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:PedrelliPaola... | lld:pubmed |
pubmed-article:16783809 | pubmed:author | pubmed-author:SchwartzFayeF | lld:pubmed |
pubmed-article:16783809 | pubmed:copyrightInfo | Copyright 2006 John Wiley & Sons, Ltd. | lld:pubmed |
pubmed-article:16783809 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16783809 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:16783809 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16783809 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16783809 | pubmed:pagination | 221-5 | lld:pubmed |
pubmed-article:16783809 | pubmed:dateRevised | 2008-3-6 | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:meshHeading | pubmed-meshheading:16783809... | lld:pubmed |
pubmed-article:16783809 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16783809 | pubmed:articleTitle | Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis. | lld:pubmed |
pubmed-article:16783809 | pubmed:affiliation | Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, USA. afarabaugh@partners.org USA. | lld:pubmed |
pubmed-article:16783809 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16783809 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:16783809 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |